The global anemia treatment market was valued at USD 10.0 billion in 2022 and is expected to grow to USD 14.9 billion by 2028 ...

DelveInsight’s ‘Chemotherapy Induced Anemia Market Insights, Epidemiology, and Market Forecast – 2032’ report delivers an ...

Disc Medicine, Inc. (NASDAQ:IRON), a biotechnology company focused on developing treatments for rare blood disorders, has ...

Anemia recurred, and hepatosplenomegaly increased ... several carbuncles on the arm that required antibiotic and surgical treatment. It was not possible to control the infection until the dose ...

Disc Medicine is in strong financial shape, advancing key candidates. Find out why IRON stock could be a strong investment ...

New data from a Phase 1b clinical trial testing Fulcrum's pociredir for sickle cell disease are expected by the middle and ...

“Iron deficiency anemia is just a later stage of iron deficiency,” says Dr. Casey O’Connell, a hematologist and an associate professor of Clinical Medicine at Keck Medicine of the University ...

Cobalt, 15 which has been used with some success in the treatment of anemia of uremia, might be considered. We did not choose to try this method of therapy. The chelating agents should be ...

Valleant’s recently released guide aims to help individuals better understand anemia, explore treatment options, and offer nutritional and lifestyle advice to support the management of ...

Panelists discuss key learnings from recent studies on lower-risk myelodysplastic syndrome (LR-MDS) treatment, identify ...

In Q1 2025, the Company will discuss the plans for NDA submission under a potential accelerated approval path for bitopertin in erythropoietic ...